105 related articles for article (PubMed ID: 6277475)
1. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
Frampton RJ; Suva LJ; Eisman JA; Findlay DM; Moore GE; Moseley JM; Martin TJ
Cancer Res; 1982 Mar; 42(3):1116-9. PubMed ID: 6277475
[TBL] [Abstract][Full Text] [Related]
2. 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines.
Colston K; Colston MJ; Fieldsteel AH; Feldman D
Cancer Res; 1982 Mar; 42(3):856-9. PubMed ID: 6895862
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites.
Frampton RJ; Omond SA; Eisman JA
Cancer Res; 1983 Sep; 43(9):4443-7. PubMed ID: 6307514
[TBL] [Abstract][Full Text] [Related]
4. High performance liquid chromatography analysis of 1,25-dihydroxyvitamin D3 receptor in malignant cells. Correlation of effects on cell proliferation and receptor concentration.
Thomas GA; Simpson RU
Cancer Biochem Biophys; 1986 Jul; 8(3):221-34. PubMed ID: 3017543
[TBL] [Abstract][Full Text] [Related]
5. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3.
Miller GJ; Stapleton GE; Ferrara JA; Lucia MS; Pfister S; Hedlund TE; Upadhya P
Cancer Res; 1992 Feb; 52(3):515-20. PubMed ID: 1370648
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.
Findlay DM; Michelangeli VP; Eisman JA; Frampton RJ; Moseley JM; MacIntyre I; Whitehead R; Martin TJ
Cancer Res; 1980 Dec; 40(12):4764-7. PubMed ID: 6254651
[TBL] [Abstract][Full Text] [Related]
7. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
8. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.
Eisman JA; Barkla DH; Tutton PJ
Cancer Res; 1987 Jan; 47(1):21-5. PubMed ID: 3024816
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of 1 alpha,25-dihydroxyvitamin D3 receptor-like molecule in ST 13 and 3T3 L1 preadipocytes and its inhibitory effects on preadipocyte differentiation.
Sato M; Hiragun A
J Cell Physiol; 1988 Jun; 135(3):545-50. PubMed ID: 2840436
[TBL] [Abstract][Full Text] [Related]
10. Frequency of 1,25-dihydroxyvitamin D3 receptor in human breast cancer.
Eisman JA; Suva LJ; Sher E; Pearce PJ; Funder JW; Martin TJ
Cancer Res; 1981 Dec; 41(12 Pt 1):5121-4. PubMed ID: 6272989
[TBL] [Abstract][Full Text] [Related]
11. 1,25-dihydroxyvitamin D3 and breast cancer.
Eisman JA; Suva LJ; Frampton RJ
Aust N Z J Surg; 1984 Feb; 54(1):17-20. PubMed ID: 6326729
[TBL] [Abstract][Full Text] [Related]
12. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
13. Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices.
Freake HC; Abeyasekera G; Iwasaki J; Marcocci C; MacIntyre I; McClelland RA; Skilton RA; Easton DF; Coombes RC
Cancer Res; 1984 Apr; 44(4):1677-81. PubMed ID: 6322984
[TBL] [Abstract][Full Text] [Related]
14. Presence of 1,25-dihydroxy vitamin D receptor in normal and abnormal breast tissue.
Eisman JA; Martin TJ; MacIntyre I
Prog Biochem Pharmacol; 1980; 17():143-50. PubMed ID: 6259652
[TBL] [Abstract][Full Text] [Related]
15. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
16. Significance of 1,25-dihydroxyvitamin D3 receptor in primary breast cancers.
Eisman JA; Suva LJ; Martin TJ
Cancer Res; 1986 Oct; 46(10):5406-8. PubMed ID: 3019526
[TBL] [Abstract][Full Text] [Related]
17. No 1,25-dihydroxyvitamin D3 receptors on osteoclasts of calcium-deficient chicken despite demonstrable receptors on circulating monocytes.
Merke J; Klaus G; Hügel U; Waldherr R; Ritz E
J Clin Invest; 1986 Jan; 77(1):312-4. PubMed ID: 3003152
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 receptor measurement in primary renal cell carcinomas and autologous normal kidney tissue.
Trydal T; Bakke A; Aksnes L; Aarskog D
Cancer Res; 1988 May; 48(9):2458-61. PubMed ID: 2833346
[TBL] [Abstract][Full Text] [Related]
19. Systematic search for 1 alpha,25-dihydroxy-vitamin D3 receptors in human breast carcinomas.
Ulmann A; Brami M; Corcos D; Bader C; Delarue JC; Contesso G
Biomed Pharmacother; 1984; 38(4):204-8. PubMed ID: 6093907
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition.
Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Evans SR
Cancer Res; 1993 Aug; 53(16):3712-8. PubMed ID: 8393379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]